Werhahn, K; Klimpe, S; Hummel, F et al.
LEVETIRACETAM: SAFETY AND EFFICACY IN ELDERLY PATIENTS WITH FOCAL EPILEPSY - A ONE YEAR OBSERVATIONAL STUDY IN 484 SUBJECTSEPILEPSIA. Bd. 50. 2009 S. 82-83
von Bardeleben, RS; Richter, C; Otto, J et al.
Long term follow up after percutaneous closure of PFO in 357 patients with paradoxical embolism: Difference in occlusion systems and influence of atrial septum aneurysm.Int J Cardiol. Bd. 134. H. 1. 2009 S. 33-41
Reuter, P; Masomi, J; Kuntze, H et al.
Low-frequency ultrasound (60 KHZ) with varied duty cycle: effects on ischemic brain tissue and the inner earJOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM. Bd. 29. 2009 S. S225-S226
Vogt, J; Paul, F; Aktas, O et al.
Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitisAnn Neurol. Bd. 66. H. 3. 2009 S. 310-22
Fischer, G; Stadie, A; Schwandt, E et al.
Minimally invasive superficial temporal artery to middle cerebral artery bypass through a minicraniotomy: benefit of three-dimensional virtual reality planning using magnetic resonance angiographyNeurosurg Focus. Bd. 26. H. 5. 2009 S. 20
Bellmann-Strobl, J; Stiepani, H; Wuerfel, J et al.
MR spectroscopy (MRS) and magnetisation transfer imaging (MTI), lesion load and clinical scores in early relapsing remitting multiple sclerosis: a combined cross-sectional and longitudinal study.Eur Radiol. Bd. 19. H. 8. 2009 S. 2066-74
Luessi, F; Sollors, J; Zieschang, K et al.
Multiple cranial nerve palsies as presenting symptom in primary Sjogren's syndromeJOURNAL OF NEUROLOGY. Bd. 256. 2009 S. S116-S117
Gelber, C; Barreiros, AP; Walz, R et al.
NEUROLOGICAL FOLLOW-UP IN PATIENTS AFTER DOMINO-LIVER TRANSPLANTATIONJOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. Bd. 14. 2009 S. 55-55
Hake, I; Schonenberger, S; Neumann, J et al.
Neuroprotection and enhanced neurogenesis by extract from the tropical plant Knema laurina after inflammatory damage in living brain tissue.J Neuroimmunol. Bd. 206. H. 1-2. 2009 S. 91-9
Glas, M; Hundsberger, T; Stuplich, M et al.
Nimustine (ACNU) plus teniposide (VM26) in recurrent glioblastoma.Oncology. Bd. 76. H. 3. 2009 S. 184-9